Abstract:Background: RNA-binding proteins (RBPs) play essential roles in post-transcriptional control of gene expression. Dysregulation of RBPs is intensively implicated in development and progression of human diseases, including cancers. However, the roles of RBPs in nasopharyngeal carcinoma (NPC), which is a distinct subtype of head and neck cancer, remain elusive. Methods: NPC-related RBPs were explored by analyzing GEO database and high-throughput proteomic data obtained from crosslinking immunoprecipitation. The expression levels of Y box binding protein 1 (YBX1) protein in NPC samples were measured by immunohistochemistry (IHC) staining. The association of YBX1 protein levels with prognosis of NPC patients was analyzed by Kaplan-Meier Plotter. The expression levels of YBX1 in NPC cells were inhibited by RNA interference. Cell growth was measured by CCK-8 assay. Cell mobility and invasiveness were measured by transwell assays. Tumorigenicity was measured by using a xenograft tumor assay. The expression levels of mRNAs or proteins were determined by qPCR or western blot assays, respectively. The mRNAs binding to YBX1 were determined by RNA immunoprecipitation (RIP) and qPCR. The effect of YBX1 on mRNA translation was measured by luciferase reporter assay. Results: In the present study, we demonstrated a differentially expressed RBPs profile between NPC and its normal counterpart. Among these aberrantly expressed RBPs, YBX1 was overexpressed in NPC. We found that YBX1 is mainly localized in the cytoplasm of NPC cells. Loss of YBX1 led to reduced cell proliferation, migration and invasiveness in vitro, and reduced tumorigenicity in vivo. Overexpression of YBX1 associates with high expression of cell cycle G2/M checkpoint modulators. In addition, YBX1 promotes AURKA protein expression by directly binding to its mRNA. Loss of YBX1 leads to reduction of AURKA protein level. Forced expression of AURKA rescues cell proliferation and invasiveness in YBX1-silenced NPC cell. Conclusions: The current study indicated that YBX1 promotes NPC cell proliferation and invasiveness through enhancing protein synthesis of AURKA.

RNA-binding motif protein RBM47 promotes tumorigenesis in nasopharyngeal carcinoma through multiple pathways

RNA Binding Motif Protein 3 (RBM3) Drives Radioresistance in Nasopharyngeal Carcinoma by Reducing Apoptosis Via the PI3K/AKT/Bcl-2 Signaling Pathway.

RNA-binding Protein YBX1 Promotes Cell Proliferation and Invasiveness of Nasopharyngeal Carcinoma Cells Via Binding to AURKA Mrna

Rbm24 Suppresses Cancer Progression by Upregulating Mir-25 to Target Malat1 in Nasopharyngeal Carcinoma

RBM15 Promotes Hepatocellular Carcinoma Progression by Regulating N6-methyladenosine Modification of YES1 Mrna in an IGF2BP1-dependent Manner.

miR-141 is involved in BRD7-mediated cell proliferation and tumor formation through suppression of the PTEN/AKT pathway in nasopharyngeal carcinoma

Inhibition of cell proliferation and radioresistance by miR-383-5p through targeting RNA binding protein motif (RBM3) in nasopharyngeal carcinoma

Downregulation of RNA Binding Protein 47 Predicts Low Survival in Patients and Promotes the Development of Renal Cell Malignancies Through RNA Stability Modification

MicroRNA-215 promoted the progression of nasopharyngeal carcinoma through targeting RB1 and activating Wnt/β-catenin pathway.

The Non-Canonical RNA Binding Protein RAN Stabilizes the Mrna of Intranuclear Stress Granule Assembly Factor G3BP1 in Nasopharyngeal Carcinoma

MYC-activated RNA N6-methyladenosine reader IGF2BP3 promotes cell proliferation and metastasis in nasopharyngeal carcinoma

Increased Expression of the RNA-binding Motif Protein 47 Predicts Poor Prognosis in Non-Small-cell Lung Cancer

Single-cell RNA binding protein regulatory network analyses reveal oncogenic HNRNPK-MYC signalling pathway in cancer

RBFOX2/GOLIM4 Splicing Axis Activates Vesicular Transport Pathway to Promote Nasopharyngeal Carcinogenesis

Rab1A promotes cancer metastasis and radioresistance through activating GSK-3/Wnt/-catenin signaling in nasopharyngeal carcinoma

Rab1A promotes cancer metastasis and radioresistance through activating GSK-3β/Wnt/β-catenin signaling in nasopharyngeal carcinoma.

Novel chimeric transcript RRM2-c2orf48 promotes metastasis in nasopharyngeal carcinoma

N6‐Methyladenosine‐Modified CBX1 Regulates Nasopharyngeal Carcinoma Progression Through Heterochromatin Formation and STAT1 Activation

BRD7 Inhibits Enhancer Activity and Expression of BIRC2 to Suppress Tumor Growth and Metastasis in Nasopharyngeal Carcinoma

Rab1A Promotes Cancer Metastasis and Radioresistance Through Activating GSK-3&#x3B2;/Wnt/&#x3B2;-catenin Signaling in Nasopharyngeal Carcinoma

BRD7 Expression and C-Myc Activation Forms a Double-Negative Feedback Loop That Controls the Cell Proliferation and Tumor Growth of Nasopharyngeal Carcinoma by Targeting Oncogenic Mir-141